FINANCIAL STATEMENTS CONSOLIDATED CASH FLOW STATEMENT For the year ended 31 December 2017 Restated 9 months Year ended ended 31 December 31 December 2017 2016 Notes m m Cash flows from operating activities Operating loss 96.2 44.5 Amortisation and impairment 16 109.7 64.0 Depreciation 17 5.7 3.4 Share-based payments 29 3.9 2.3 Increase decrease in inventories 5.9 0.8 Decrease increase in trade and other receivables 17.2 13.0 Decrease increase in trade and other payables 6.9 3.8 Foreign exchange movements 0.2 3.0 Other non-cash items 0.4 0.8 Cash from operating activities before taxation 26.9 19.0 Research and development tax credits received 2.1 2.4 Corporation tax paid 2.9 2.6 Net cash inflow from operating activities after taxation 26.1 18.8 Cash flows from investing activities Skyepharma merger, net of cash acquired 27 25.0 Purchase of property, plant and equipment 9.5 2.6 Proceeds from sale of property, plant and equipment 2.9 Funding provided to ESOP trusts 1.5 Net cash outflow from investing activities 9.5 26.2 Net cash inflow outflow before financing activities 16.6 7.4 Cash flows from financing activities Share buyback programme 1.4 Proceeds from exercise of employee share options 0.5 0.3 Merger transaction costs 2.5 Funding provided to ESOP trusts 1.8 Interest paid and other finance charges 0.3 0.2 Repayment of secured mortgage borrowings 0.2 0.2 Net cash outflow from financing activities 3.2 2.6 Foreign exchange 2.2 2.7 Increase decrease in cash and cash equivalents 11.2 7.3 Cash and cash equivalents at the beginning of the period 92.5 99.8 Cash and cash equivalents at the end of the period 103.7 92.5 Following an FRC corporate reporting review of the Groups 2016 Annual Report and Accounts, in accordance with IAS 7 paragraph 16, exceptional merger transaction costs disclosed as cash flows from investing activities in the 2016 financial statements have been restated as cash flows from operating activities and cash flows from financing activities within the 2016 comparative above.
This restatement does not impact closing cash or net debt: it solely relates to the classification of these 2016 exceptional cash outflows as financing and operating activities as opposed to investing activities as previously reported.
Refer to note 30 Cash flow information.
The accompanying notes form an integral part of these consolidated financial statements.
Annual Report and Accounts 2017 Vectura Group plc 121
